Table 1.
Hematologic findings in the three groups of dogs included in the study
| Group | A | B | C | |||
|---|---|---|---|---|---|---|
| Day | 1 | 7 | 14 | 21 | ||
| PCV (%) | 45.64 ± 3.11 | 42.07 ± 1.88 | 43.20 ± 1.71 | 43.55 ± 1.55 | 46.72 ± 1.61 | 45.89 ± 1.09 |
| WBC (×109/L) | 20.21 ± 2.46** | 26.93 ± 2.56** | 24.57 ± 2.88** | 18.36 ± 1.87** | 11.78 ± 1.14** | 9.47 ± 0.79 |
| PLT (×109/L) | 334.60 ± 54.56 | 351.20 ± 45.44 | 367.00 ± 25.17* | 303.20 ± 27.16 | 434.25 ± 44.35* | 246.80 ± 26.55 |
PCV, white blood cell (WBC) and platelet (PLT) counts in dogs affected with steroid responsive meningitis arteritis (SRMA; group A, n = 10 at days 1, 7, 14, and 21 after treatment onset), dogs with hyperadrenocorticism (PDH; group B, n = 20), and control dogs (group C, n = 16). Values are presented as mean ± SEM. Values marked with * differ statistically from the control group: *P < 0.05 and **P < 0.01.